Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

  • HOME
  • BROWSE ARTICLES
  • Previous issues
16
results for

Previous issues

Article category

Keywords

Previous issues

Prev issue Next issue

Volume 8(3); September 2002

Original Articles

Isolation and Culture of Pig Hepatocyte in Large Scale for the Application of Bioartificial Liver System
Yu Jeong Chung2, Hyuk-Joon Lee1, Young Taeg Koh3, Sang Beom Kim1 , Seong Hoon Kim1, Seokho Choi1, Nam-Joon Yi11, Seong-Hwan Chang1, Eun Lan Yang2, Kyung-Suk Suh1, Yoon Shin Lee4 , and Kuhn Uk Lee1,2
Korean J Hepatol 2002;8(3):249-255.
Background/Aims
Acute hepatic failure is a serious problem. Its mortality reaches up to 80%. Only liver transplantation has been accepted as a definite treatment for patients with hepatic failure but shortage of donor organs is the main obstacle of this approach. A possible solution to this problem is a bioartificial liver system, perfusion of patients blood to isolated hepatocyte. In this study, we performed the isolation and culture of pig hepatocyte in large scale for the application of bioartificial liver system. Methods: Hepatocyte isolation was performed by two-step collagenase method via portal vein perfusion in 10kg female pigs. After that, we compared the functional differences of the spheroid culture to the monolayer culture of hepatocyte. The viability and the function of hepatocyte were assessed using trypan-blue exclusion test and the measurement of the rate of ureagenesis and ammonia removal. Results: The average viability and yield of hepatocyte were 86.8±8.0 % and 7.8±5.4×109, respectively. The spheroid culture was superior to the monolayer culture in functional aspect of hepatocyte, and their differences, especially for ammonia removal, were more apparent in parallel with culture time. Conclusions: For hepatocyte isolation, we obtained sufficient viability and yield of hepatocyte for clinical usage of bioartificial liver system. The function of hepatocyte seems to be better in the spheroid culture than in the monolayer culture. Further studies are needed for application of bioartificial liver system in clinical setting. (Korean J Hepatol 2002;8:249-255)
  • 3,815 View
  • 24 Download
Five - year Follow - up of Clinical and Laboratory Data of Early Liver Cirrhosis Patients Confirmed by Liver Biopsy
Dong Uk Kim,Geun Tae Park,Dong Hee Koh,Hyun Seok Cho,Young Hoon Kim,Sung Gon Shim,Jin Bae Kim,Sung Hee Lee,Ho Soon Choi,Joon Soo Hahm,Min Ho Lee
Korean J Hepatol 2002;8(3):256-263.
Background/Aims
It is important to evaluate the general status of the liver including the structural and inflammatory aspects, as well as the functional aspects, in order to determine a patient`s treatment modality and prognosis. Methods: 55 Child-Pugh class A liver cirrhosis patients confirmed by liver biopsy have been categorized into 4 groups based on the shunt index and p-value(Y= 3.3431-0.8160×ALT/AST ratio-0.0343× prothrombin time+2.6963×shunt index, p = ey/(ey+1)), which was obtained by Thallium- 201 scan ; group I - shunt index less than 0.3 and p-value less than 0.7; group II - shunt index less than 0.3 and p-value more than 0.7; group III - shunt index more than 0.3 and p-value less than 0.7; and group IV - shunt index more than 0.3 and p-value more than 0.7. Statistical analyses used were ANOVA, paired t-test, and Chi-square test. Results: 1. The laboratory data after a 5-year follow-up also showed a significant difference between four groups. 2. In group IV, the Child-Pugh class after 5 years worsened, and complications of liver cirrhosis such as esophageal varix, ascites, and hepatic encephalopathy occurred more frequently. 3. In group II, the laboratory data after a 5-year follow-up indicated some improvement. Conclusion: It can be seen that even early in patients with initially the same cirrhosis, the course of the illness can progress to a variety of different situations. The measurement of shunt index and the p-value of cirrhosis will be more helpful in the follow-up evaluation and predicting its prognostic index in liver cirrhosis patients. (Korean J Hepatol 2002;8:256-263)
  • 3,340 View
  • 17 Download
Comparison of Doppler Ultrasonography and Hepatic Venous Pressure Gradient in Assessing Portal Hypertension in Liver Cirrhosis
Phil Ho Jeong, M.D., Soon Koo Baik, M.D., Yeun Jong Choi, M.D., Dong Hoon Park, M.D., Moon Young Kim, M.D., Hyun Soo Kim, M.D., Dong Ki Lee, M.D., Sang Ok Kwon, M.D., Young Ju Kim, M.D.*, Joong Wha Park, M.D.*, and Nam Dong Kim, M.D.†
Korean J Hepatol 2002;8(3):264-270.
Background/Aims
This prospective study aimed to determine if Doppler ultrasonography can be representative of hepatic venous pressure gradient (HVPG) in assessing the severity of portal hypertension and response to drug reducing portal pressure. Methods: The HVPG and the parameters of Doppler ultrasonography including portal venous velocity (PVV) and splenic venous velocity, the pulsatility and resistive index of hepatic, splenic and renal arteries were measured in 105 patients with liver cirrhosis. In 31 patients the changes of hepatic venous pressure gradient and portal venous velocity after administration of terlipressin were evaluated. The patients who showed a reduction in HVPG of more than 20% of the baseline were defined as responders to terlipressin. Results: Any Doppler ultrasonographc parameters did not correlate with HVPG. Both HVPG and PVV showed a highly significant reduction after the administration of terlipressin(-28.3± 3.9%, -31.2± 2.2% respectively). However, PVV decreased significantly not only in responders(31.7± 2.4%) but also in nonresponders(29.5± 6.1%). Conclusion: Doppler ultrasonography can not be representative of HVPG in assessing the severity of portal hypertension and response to drug reducing portal pressure in liver cirrhosis. (Korean J Hepatol 2002;8:264-270)
  • 4,461 View
  • 22 Download
Prevalence and Risk Factors of Significant Intrapulmonary Shunt in Cirrhotic patients awaiting liver transplantation
Ji Min Lee,Moon Seok Choi,Sang Chol Lee,Seung Woo Park,Mun Hee Bae,Joon Hyeok Lee,Kwang Cheol Koh,Seung Woon Paik,Poong Lyul Rhee,Jae Jun Kim,Jong Chul Rhee
Korean J Hepatol 2002;8(3):271-276.
Backgrounds/Aims
Hepatopulmonary syndrome is a condition of severe hypoxia with intrapulmonary shunt (IPS) in the setting of hepatic dysfunction. Liver transplantation has been suggested as a definite treatment for hepatopulmonary syndrome with reversal of IPS in some patients. Inconsistency of response and inability to predict reversibility, however, are significant problems. We performed this study to evaluate the prevalence of significant IPS in pretransplantation cirrhotic patients and to find any risk factors of IPS. Methods: Fifty-seven patients (M:F = 38:19, median age 49 years (range 18 - 71)) with liver cirrhosis awaiting liver transplantation were serially included. Their IPS status was evaluated using contrastenhanced echocardiography. Significant shunt was defined as a shunt of grade ≥2. Results: Significant IPS was detected in 30 (52.6%) among 57 patients. Significant shunt was found in 24 (63.2%) of 38 Child-Pugh class C patients and in 6 (31.6%) of 19 Child-Pugh class A or B patients (p<0.05). No significant difference in prevalence of significant shunt was seen according to age, sex, presence or absence of hepatocellular carcinoma, ascites, hepatic encephalopathy, and gastroesophageal varix. Conclusion: Significant intrapulmonary shunt is a common finding in cirrhotic patients awaiting liver transplantation. Child-Pugh class C is the risk factor associated with high prevalence of significant shunt. (Korean J Hepatol 2002;8:271-276)
  • 3,608 View
  • 25 Download
Relationship of Propranolol Pharmacokinetic Parameters with Portosystemic Shunt in CCl4 - induced cirrhotic Rats
Dong Hee Koh, M.D., Geun Tae Park, M.D., Jung Mi Kim, M.D., Yeong Seop Yun, M.D., Sung Hee Lee, M.D., Dong Uk Kim, M.D., Jin Bae Kim, M.D., Yun Yung Choi, M.D.*, Ju Seop Kang, M.D.**, Ho Soon Choi, M.D., Joon Soo Hahm, M.D., Min Ho Lee, M.D.
Korean J Hepatol 2002;8(3):277-287.
Background
This study was designed to determine the relationship of propranolol pharmacokinetic parameters with portosystemic shunt in CCl4-induced cirrhotic rats. Methods: Cirrhotic rats(n=6) were induced by intramuscular injection of CCl4 in olive oil(two time per weeks) for 12 weeks. Controls (n=6) were injected intramuscularly with the same dose of olive oil for 12 weeks. We evaluated the amount of portosystemic shunt by thallium-201 per rectal scintigraphy. After intravenous bolus injection of propranolol (2mg/kg) to rats, the serum propranolol concentrations were analyzed by a HPLC-fluorimetric detector system. Pharmacokinetic parameters such as C0, AUC, t1/2(β), and CLp were determined in each group. Then, a small amount of heptic tissue was obtained and subjected to determination of the hepatic collagen content by quantitating 4-hydroxyproline and were inspected by microscope after hematoxylin and eosin stain. Results: In liver biopsy, liver fibrosis progressed in CCl4-induced cirrhotic rats. The serum concentrations of propranolol were significantly (p<0.01) elevated in CCl4-induced cirrhotic rats. Mean amount of 4-hydroxyproline, mean H/L ratio, and mean AUC in CCl4-induced cirrhotic rats was significantly (p<0.01) higher than that in control rats. There was a relationship between AUC, H/L ratio, and amount of 4-hydroxyproline. Conclusion: H/L ratio may help in the selection of drug dosage (especially blood flow dependent drug) in pre-clinical studies for chronic liver disease during the drug development process. (Korean J Hepatol 2002;8:277-287)
  • 3,526 View
  • 19 Download
Prospective Randomized Trial of Intravenous Ciprofloxacin for Prevention of Bacterial Infection in Cirrhotic Patients with Esophageal Variceal Bleeding
Sung Noh Hong, Beom Jin Kim, Sun Young Lee, Choon Young Lee, Min Kyu Ryu, Moon Seok Choi, Joon Hyoek Lee, Poong Lyul Rhee, Kwang Cheol Koh, Jae J Kim, Seung Woon Paik, Jong Chul Rhee, and Kyoo Wan Choi
Korean J Hepatol 2002;8(3):288-296.
Background/Aims
In cirrhotic patients with esophageal variceal bleeding, bacterial infections are a frequent complication. Oral antibiotic prophylaxis decreases the incidence of bacterial infections. The administration of oral antibiotics, however, may be difficult in some cirrhotic patients with active bleeding.The purpose of this study was to assess the efficacy of prophylactic intravenous antibiotics for the prevention of bacterial infections in cirrhotic patients with esophageal variceal bleeding. Methods: From December 1998 to September 2001, a total of 40 consecutive cirrhotic patients with Child-Pugh class B or C were enrolled after emergent endoscopic esophageal variceal ligation (EVL) was taken because of esophageal variceal bleeding. Enrolled patients were randomized into a treatment group and a control group. The treatment group (n=20) received the intravenous ciprofloxacin 200mg IV q 12 hours for 3 days while the control group(n=20) didn,t. Results: Bacterial infection developed in nine patients (45%) of the control group and only two patients (10%) in the treatment group. The incidence of bacterial infections was significantly lower in the treatment group than the control group (p<0.005). The hospital cost and length of hospital stay decreased in the treatment group compared with the control group (p<0.001). There were no differences in the hospital course and mortality within 30 days between the two groups. Conclusions: In cirrhotic patients with variceal bleeding and with Child-Pugh class B or C, the use of intravenous ciprofloxacin for 3 days after EVL was not only effective in the prevention of bacterial infections but also cost-effective. (Korean J Hepatol 2002;8:288-296)
  • 3,961 View
  • 43 Download
Expression Patterns of E - cadherin and β - catenin According to Clinicopathological Characteristics of Hepatocellular Carcinoma
Si Hyun Bae, M.D.1,4, Eun Sun Jung, M.D.2, Young Min Park, M.D.1,4, Jeong Won Jang, M.D.1,4, Jong Young Choi, M.D.1,4, Se Hyun Cho, M.D.1,4, Seung Kew Yoon, M.D.1,4, Byung Min Ahn, M.D.1,4, Sang Bok Cha, M.D.1,4, Kyu Won Chung, M.D.1,4, Hee Sik Sun, M.D.1,4, Doo Ho Park, M.D.1,4, Byung Kee Kim, M.D.2, Dong Goo Kim, M.D.3
Korean J Hepatol 2002;8(3):297-303.
Background/Aims
E-cadherin is involved in intercellular binding and cellular polarity formation. β-catenin plays a fundamental role in regulation of the E-cadherin cell adhesion complex. The abnormalities of the components of the complex may disrupt this adhesive function. We investigated the expression patterns of E-cadherin and β-catenin to determine the clinical significance of these proteins in hepatocellular carcinoma. Materials/Methods: Thirty-six hepaticellular carcinoma tissues and adjacent non-tumor specimens were analyzed. Subcellular distribution of E-cadherin and β-catenin was examined by immunohistochemistry staining. We evaluated the patterns of the expression, and investigated the relationship with the cause of HCC; level of AFP; TNM stage; tumor size; growth types; metastasis; differentiation grade of HCC; and presence of portal vein thrombosis. Results: Immunohistochemistry showed that all non-tumor tissues had membranous type staining of E-cadherin. All non-tumor tissues showed cytoplasmic type staining of β-catenin, but no β -catenin accumulation in nuclei was found. 58% (21/36) of HCC showed positive expression of E-cadherin in cytoplasmic membrane. The cytoplasmic expression of β-catenin in HCC was 83% (30/36); nuclear expression in 14% (5/36); and no staining in 3% (1/36). Nuclear β-catenin expression was observed in none (0/4) of the well-differentiated HCC; 17%(3/9) of moderate-differentiated HCC; and 17%(2/6) of poorly-differentiated HCC. There were no relationships between E-cadherin and β-catenin expression with other clinicopathologic factors. Conclusions: Loss of cytoplasmic staining of E-cadherin and nuclear accumulation of β-catenin were observed in HCC. Nuclear accumulation of β-catenin was not found in well differentiated HCC but was found in poorly differentiated HCC. (Korean J Hepatol 2002;8:297-303)
  • 3,872 View
  • 28 Download
Radiation Therapy for Bone Metastasis from Hepatocellular Carcinoma
Woong Sub Koom, M.D., Jinsil Seong, M.D., Min Jeong Lee. M.D., Hee Cheul Park, M.D., Kwang Hyub Han, M.D.*, Jae Yoon Chon, M.D.*, Young Myoung Moon, M.D.*, and Chang Ok Suh, M.D.
Korean J Hepatol 2002;8(3):304-311.
Background
/Aim: Recent advances in both diagnosis and treatment have markedly improved the prognosis in patients with hepatocellular carcinoma (HCC). Bone metastasis has become a clinical problem in the treatment of HCC patients. The purpose of this study was to evaluate the palliative effect of radiotherapy for painful bone metastasis from HCC. Methods: From January 1991 to June 2000, 51 patients (77 sites) with painful bone metastasis from HCC were retrospectively analyzed. Ages ranged from 21 to 80 years (median 55 years). The male:female ratio was 7.5:1. Synchronous or metachronous bone metastasis was seen in 20 (39%) and 31 patients (61%), respectively. The most common symptom of bone metastasis was pain (45 patients, 88%). Twenty-one patients (41%) had a solitary bone metastasis while 30 (59%) had multiple ones. The sites of bone metastasis, in order of frequency, were the vertebra (38), rib (20), and pelvis (19). The total radiation dose ranged from 12.5 to 50 Gy (median 30 Gy). The Wisconsin Brief Pain Questionnaire was used to evaluate pain response. Results: The overall 1 and 2 year survival rates from the time of bone metastasis were 15% and 4%, respectively. The median survival time was 5 months. Intrahepatic stage(p=0.014), and metastasis to other organs(p=0.019) were significant prognostic factor for survival by univariate analysis. There was, however, no independent prognostic factor on multivariate analysis. Pain relief after radiotherapy was achieved for 56 sites (73%). Conclusion: The expected life span (median 5 months) in this group of patients suggests a strong necessity for effective treatment for symptomatic palliation. Radiation therapy was effective in pain palliation for bone metastasis from HCC, and this could improve patients` quality of life. (Korean J Hepatol 2002;8:304-311)
  • 4,365 View
  • 19 Download

Case Reports

A Case of Acute Hepatitis E
Nam Jin Kim,June Sung Lee,Kyung Ah Kim,Hye Ran Lee,Jang Weon Oh,Yi Dae Cho,Woo Jin Lee,Hyun Wook Baik,Young Bin Jeon,Chung Yong Kim
Korean J Hepatol 2002;8(3):312-316.
Hepatitis E is an infectious viral disease with clinical and morphologic features of acute hepatitis. Although HEV infection is endemic in the Indian subcontinent, Southeast and Central Asia, a large outbreak of hepatitis E was identified in China. Smaller outbreaks have been observed in the Middle East, northern and western parts of Africa, and Mexico. Sporadic hepatitis E also has been observed in several countries. In nonendemic regions, the sporadic cases of hepatitis E are almost always associated with travel to HEV-endemic regions. In Korea, there has been no report on hepatitis E. Recently, we experienced a case of acute icteric hepatitis in which serologic study showed seroconversion of IgM anti-HEV. The patient did not have any travel history to an HEV-endemic area. We report this as an initial case of acute hepatitis E in Korea. (Korean J Hepatol 2002;8:312-316)
  • 4,215 View
  • 40 Download
A Case of Acute Cholestatic Hepatitis Associated with Orlistat
Doh Hyun Kim , Eun Hee Lee , Jae Chul Hwang , Jai Hak Jeung , Jae Youn Cheong Sung Won Cho , Young Bae Kim
Korean J Hepatol 2002;8(3):317-320.
Orlistat(Xenical®, Roche) is considered a safe and effective drug to treat obesity by reduced absorption of 30% digested fat. To date, no serious adverse effects affecting the liver have been published except a case of subacute hepatic failure leading to liver transplantation in a young women with moderate obesity treated with orlistat. We report a case of acute cholestatic hepatitis in a young woman with moderate obesity treated with orlistat: a 33-year-old female admitted for the evaluation of jaundice. Abdominal ultrasonography, ERCP, routine chemistry, viral markers, and a fine needle biopsy of liver were performed. Microscopic findings of the liver biopsy specimen were compatible with acute cholestatic hepatitis. After steroid therapy, liver function was improved. (Korean J Hepatol 2002;8:317-320)
  • 4,557 View
  • 37 Download
A Case of Idiopathic Hypereosinophilic Syndrome with Hepatic Involvement in a 5 - Year - Old Boy
Young Mi Kim, M.D., Yoon Jin Lee, M.D., Jae Hong Park, M.D., Jun Woo Lee, M.D.1, and Chang Hun Lee, M.D.2
Korean J Hepatol 2002;8(3):321-326.
Idiopathic hypereosinophilic syndrome is defined as the presence of prolonged eosinophilia without an identifiable underlying cause and with evidence of end-organ dysfunction. The organs involved are the heart, bone marrow, nervous system, lungs, liver, skin, and gastrointestinal tract. Hepatic involvement is found in about 30% of patients of idiopathic hypereosinophilic syndrome. It occurs rarely in infants and children. In this report, we experienced one case of idiopathic hypereosinophilic syndrome with hepatic involvement in a 5-year-old boy who complained of intermittent fever and right upper quadrant abdominal pain. An abdominal ultrasound examination revealed an ill-defined low-echoic lesion in the liver. Pathologic findings of a biopsy specimen clearly showed the infiltration of eosinophils in the liver. Laboratory data disclosed absolute eosinophilia. There was no evidence of allergic disease or parasitic infestation. (Korean J Hepatol 2002;8:321-326)
  • 3,770 View
  • 24 Download
A Case of Refractory Hepatic Hydrothorax That Was Not Treated by Transjugular Intrahepatic Portosystemic Shunt
Hye Won Park,Woong Huh,Sung Jun Kim,Won Chang Shin,Won Chung Choi,Jin Ho Lee
Korean J Hepatol 2002;8(3):327-330.
Refractory hepatic hydrothorax has been treated by conservative methods: salt and water restriction, diuretics, thoracentesis, thoracostomy, and pleurodesis. The results, however, havebeen disappointing. Recently, TIPS has emerged as a new method for refractory hepatic hydrothorax, but it may lead to fatal complications. We report a case of refractory hepatic hydrothorax that was not treated by TIPS despite of successful control of ascitest. (Korean J Hepatol 2002;8:327-330)
  • 3,564 View
  • 18 Download
A Case of Resection of Biloma with Hepatocellular Carcinoma after Embolization
Won Kyu Park, M.D., Jay Chun Chang, M.D., Heon Zu Lee, M.D.*, Hong Jin Kim, M.D.†, Joon Hyuk Choi, M.D.‡, and Mi Jin Gu, M.D.‡
Korean J Hepatol 2002;8(3):331-335.
Intrahepatic biloma is one of the rare complications occurring after transcatheter arterial chemoembolization (TACE). Biloma after TACE may result from the development of peripheral bile duct necrosis caused by microvascular damage of the peribiliary capillary plexus, and intrahepatic ductal stenosis. We report a case of resection of intrahepatic biloma with hepatocellular carcinoma after TACE. (Korean J Hepatol 2002;8:331-335)
  • 4,014 View
  • 27 Download

Liver Pathology

Biliary Papillomatosis
Hyun Lyoung Koo,Eun Sil Yu
Korean J Hepatol 2002;8(3):336-339.
  • 3,880 View
  • 15 Download

Liver Imaging

Spontaneous Intrahepatic Portosystemic Shunt
Joon Koo Han,Se Hyung Kim
Korean J Hepatol 2002;8(3):340-342.
  • 3,615 View
  • 19 Download

EM Image in Hepatology

  • 3,195 View
  • 20 Download